STAAR SURGICAL CO 8-K

What Happened STAAR Surgical Company filed an 8-K (dated June 9, 2026) reporting that its Compensation Committee approved increases to the pay package for Deborah Andrews, the Company’s Interim Co‑Chief Executive Officer and Chief Financial Officer. Her annual base salary was raised from $512,000 to $575,000, and her target annual cash bonus was increased from 55% to 60% of base salary. Both changes are effective June 8, 2026.

Key Details

• Approved by the Compensation Committee of the Board of Directors.
• Base salary: $512,000 → $575,000 (effective June 8, 2026).
• Target annual cash bonus: 55% → 60% of base salary (effective June 8, 2026).
• 8-K filed on June 9, 2026; filing signed by Warren Foust, Interim Co‑CEO & COO.

Why It Matters This is an executive compensation change (Item 5.02) that increases the company’s near‑term personnel costs and signals the board’s intent to retain and reward the interim leader responsible for strategic and operational objectives. For investors, the item provides transparency on management pay and may be relevant when assessing STAAR’s governance, executive incentives, and future operating expenses. The filing does not include changes to equity awards or other benefits.